SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 52 filers reported holding SATSUMA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $29,472 | -22.5% | 42,193 | -0.1% | 0.00% | – |
| Q4 2022 | $38,009 | -85.0% | 42,232 | -0.1% | 0.00% | – |
| Q3 2022 | $254,000 | +61.8% | 42,269 | +11.4% | 0.00% | – |
| Q2 2022 | $157,000 | +6.1% | 37,935 | -2.1% | 0.00% | – |
| Q1 2022 | $148,000 | -16.4% | 38,758 | -1.3% | 0.00% | – |
| Q4 2021 | $177,000 | +18.0% | 39,286 | +22.0% | 0.00% | – |
| Q3 2021 | $150,000 | -12.3% | 32,198 | +32.5% | 0.00% | – |
| Q2 2021 | $171,000 | -73.4% | 24,300 | -77.7% | 0.00% | – |
| Q1 2021 | $642,000 | +13.4% | 108,736 | -11.4% | 0.00% | – |
| Q4 2020 | $566,000 | +17.7% | 122,740 | -0.7% | 0.00% | – |
| Q3 2020 | $481,000 | -86.8% | 123,574 | -2.7% | 0.00% | -100.0% |
| Q2 2020 | $3,652,000 | +186.9% | 127,006 | +114.7% | 0.00% | – |
| Q1 2020 | $1,273,000 | +21.7% | 59,154 | +11.3% | 0.00% | – |
| Q4 2019 | $1,046,000 | +905.8% | 53,146 | +663.5% | 0.00% | – |
| Q3 2019 | $104,000 | – | 6,961 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alambic Investment Management, L.P. | 20,711 | $81,000 | 0.89% |
| RA Capital Management | 4,681,858 | $18,212,000 | 0.33% |
| Ghost Tree Capital, LLC | 200,000 | $778,000 | 0.22% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,885,939 | $7,336,000 | 0.13% |
| Virtu Financial LLC | 39,062 | $152,000 | 0.03% |
| Quantitative Systematic Strategies LLC | 14,195 | $55,000 | 0.01% |
| Cetera Advisor Networks LLC | 85,000 | $331,000 | 0.01% |
| BAILARD, INC. | 38,600 | $150,000 | 0.01% |
| Chicago Partners Investment Group LLC | 14,081 | $52,000 | 0.01% |
| EXANE DERIVATIVES | 4,078 | $15,863,000 | 0.01% |